EORTC-22932-ROG

Phase III randomized study on the role of the booster dose of postoperative radiotherapy in patients with early stage carcinomas of head and neck (Jointly with the EORTC Radiotherapy Cooperative Group)
Trial StatusAll trial activities ended
DatesDate of activation: 09-Feb-94
Closed on : 20-Nov-95
Data management at EORTCFull
Phase3
Randomized trialYes
TypeAdvanced
Targeted Sample size408
Number of steps1
Drug
Study Staff
Type of cancerHead and Neck
Participating GroupsEORTC Radiation Oncology Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT number
EudraCT
@
Back to Protocol section